Simplify Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Simplify Asset Management's PCRX Position: Q3 2026 in Review
Simplify Asset Management reduced its Pacira BioSciences (PCRX) stake by 0.32% in Q3 2026, selling an estimated $6.81K and leaving 82,814 shares worth $2.07M. The position accounts for 0.03% of the portfolio, ranked #57.
Simplify Asset Management first reported a position in PCRX in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.33M in Q1 2025. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Simplify Asset Management held 82,814 shares of Pacira BioSciences worth $2.07M as of Q3 2026.
- Simplify Asset Management sold 269 Pacira BioSciences shares in Q3 2026, an estimated $6.81K.
- Pacira BioSciences made up 0.03% of Simplify Asset Management's portfolio in Q3 2026, its #57 holding.
- Simplify Asset Management first reported a position in Pacira BioSciences in Q4 2024 and has held it in 8 quarters since.
- Simplify Asset Management's Pacira BioSciences position peaked at $3.33M in Q1 2025.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Simplify Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.